Sirtuin 1: A Dilemma in Transplantation

Sirtuin 1, a member of sirtuin family of histone deacetylase enzymes, has been implicated in a variety of physiologic and pathologic events, including energy metabolism, cell survival, and age-related alterations. In view of the anti-inflammatory properties of sirtuin 1 along with its protective rol...

Full description

Saved in:
Bibliographic Details
Main Authors: Sara Assadiasl, Nuala Mooney, Bahareh Mohebbi, Yousef Fatahi, Narjes Soleimanifar
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2020/9012980
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560897171652608
author Sara Assadiasl
Nuala Mooney
Bahareh Mohebbi
Yousef Fatahi
Narjes Soleimanifar
author_facet Sara Assadiasl
Nuala Mooney
Bahareh Mohebbi
Yousef Fatahi
Narjes Soleimanifar
author_sort Sara Assadiasl
collection DOAJ
description Sirtuin 1, a member of sirtuin family of histone deacetylase enzymes, has been implicated in a variety of physiologic and pathologic events, including energy metabolism, cell survival, and age-related alterations. In view of the anti-inflammatory properties of sirtuin 1 along with its protective role in ischemia reperfusion injury, it might be considered as contributing to the promotion of transplantation outcome. However, the potential ability of sirtuin 1 to induce malignancies raises some concerns about its overexpression in clinic. Moreover, despite the findings of sirtuin 1 implication in thymic tolerance induction and T regulatory (Treg) cells survival, there is also evidence for its involvement in Treg suppression and in T helper 17 cells differentiation. The identification of sirtuin 1 natural and synthetic activators leads to the proposal of sirtuin 1 as an eligible target for clinical interventions in transplantation. All positive and negative consequences of sirtuin 1 overactivation/overexpression in the allograft should therefore be studied thoroughly. Herein, we summarize previous findings concerning direct and indirect influences of sirtuin 1 manipulation on transplantation.
format Article
id doaj-art-b9d7a5555dcc40eda3f07cc416a67c6d
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-b9d7a5555dcc40eda3f07cc416a67c6d2025-02-03T01:26:25ZengWileyJournal of Transplantation2090-00072090-00152020-01-01202010.1155/2020/90129809012980Sirtuin 1: A Dilemma in TransplantationSara Assadiasl0Nuala Mooney1Bahareh Mohebbi2Yousef Fatahi3Narjes Soleimanifar4Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, IranHuman Immunology and Immunopathology, Inserm UMR 976, Paris, FranceMolecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, IranDepartment of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranMolecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, IranSirtuin 1, a member of sirtuin family of histone deacetylase enzymes, has been implicated in a variety of physiologic and pathologic events, including energy metabolism, cell survival, and age-related alterations. In view of the anti-inflammatory properties of sirtuin 1 along with its protective role in ischemia reperfusion injury, it might be considered as contributing to the promotion of transplantation outcome. However, the potential ability of sirtuin 1 to induce malignancies raises some concerns about its overexpression in clinic. Moreover, despite the findings of sirtuin 1 implication in thymic tolerance induction and T regulatory (Treg) cells survival, there is also evidence for its involvement in Treg suppression and in T helper 17 cells differentiation. The identification of sirtuin 1 natural and synthetic activators leads to the proposal of sirtuin 1 as an eligible target for clinical interventions in transplantation. All positive and negative consequences of sirtuin 1 overactivation/overexpression in the allograft should therefore be studied thoroughly. Herein, we summarize previous findings concerning direct and indirect influences of sirtuin 1 manipulation on transplantation.http://dx.doi.org/10.1155/2020/9012980
spellingShingle Sara Assadiasl
Nuala Mooney
Bahareh Mohebbi
Yousef Fatahi
Narjes Soleimanifar
Sirtuin 1: A Dilemma in Transplantation
Journal of Transplantation
title Sirtuin 1: A Dilemma in Transplantation
title_full Sirtuin 1: A Dilemma in Transplantation
title_fullStr Sirtuin 1: A Dilemma in Transplantation
title_full_unstemmed Sirtuin 1: A Dilemma in Transplantation
title_short Sirtuin 1: A Dilemma in Transplantation
title_sort sirtuin 1 a dilemma in transplantation
url http://dx.doi.org/10.1155/2020/9012980
work_keys_str_mv AT saraassadiasl sirtuin1adilemmaintransplantation
AT nualamooney sirtuin1adilemmaintransplantation
AT baharehmohebbi sirtuin1adilemmaintransplantation
AT youseffatahi sirtuin1adilemmaintransplantation
AT narjessoleimanifar sirtuin1adilemmaintransplantation